Hims & Hers Projects Q4 Revenue Between $875M and $895M Amid GLP-1 Expansion
Hims & Hers Health (HIMS) reported significant momentum in its latest quarterly update, noting that revenue growth accelerated to nearly 50%. The company is currently scaling its operations, serving approximately 3 million users across four continents. Looking ahead, management provided a strong Q4 revenue guidance range of $875 million to $895 million. To drive this growth, the company plans to expand its GLP-1 medication assortment and launch an aggressive international marketing campaign to capture broader market share in the telehealth sector.
Tickers: $HIMS
Topics: earnings report revenue growth telehealth